Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Revive Therapeutics Ltd (RVV.CN)

Revive Therapeutics Ltd (RVV.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 36,888
  • Shares Outstanding, K 163,946
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -0.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.11
Trade RVV.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings -0.02 on 03/31/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.225 unch
on 10/23/20
0.320 -29.69%
on 09/28/20
-0.030 (-11.76%)
since 09/23/20
3-Month
0.220 +2.27%
on 07/30/20
0.460 -51.09%
on 08/05/20
-0.030 (-11.76%)
since 07/23/20
52-Week
0.025 +800.00%
on 12/16/19
0.460 -51.09%
on 08/05/20
+0.175 (+350.00%)
since 10/23/19

Most Recent Stories

More News
InvestmentPitch Media Video Discusses Revive Therapeutics' supply agreement with Havn Life Sciences for Psychedelic Compounds - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2020) - Revive Therapeutics (CSE: RVV) (OTC PINK: RVVTF), a specialty life sciences company focused on the research and development of therapeutics...

HAVN.CN : 0.970 (+14.12%)
RVVTF : 0.1729 (-4.48%)
RVV.CN : 0.225 (-4.26%)
Stocks in play: Revive Therapeutics Ltd.

Announced it has signed a supply agreement with Havn Life Sciences Inc. (CSE:HAVN ) (FRA:5NP) to source ...

RVV.CN : 0.225 (-4.26%)
The Potential $100 Billion Psychedelics Boom Investors Should Watch

Much like cannabis, psychedelics are quickly going mainstream – and fast, most notably psilocybin. ...

RVVTF : 0.1729 (-4.48%)
HAVN.CN : 0.970 (+14.12%)
MMEDF : 1.0100 (+3.06%)
CMPS : 37.20 (-3.10%)
NUMI.VN : 0.425 (+11.84%)
JNJ : 145.04 (-0.14%)
RVV.CN : 0.225 (-4.26%)
Stocks in play: Revive Therapeutics Ltd.

Announced an update on the Company’s U.S. Food & Drug Administration Phase 3 clinical trial to evaluate ...

RVV.CN : 0.225 (-4.26%)
The World May be Nearing Treatments for the Growing Pandemic

At the moment, the CV-19 pandemic shows no signs of slowing. To date, there are nearly 33.4 million ...

RVVTF : 0.1729 (-4.48%)
MRNA : 71.50 (+1.38%)
GILD : 60.22 (-0.94%)
REGN : 579.81 (+0.71%)
PFE : 37.94 (-0.63%)
RVV.CN : 0.225 (-4.26%)
Stocks in play: Revive Therapeutics Ltd.

Provided a corporate update on its psychedelics therapeutics programs specifically as it relates to ...

RVV.CN : 0.225 (-4.26%)
RVVTF : 0.1729 (-4.48%)
These Could be Some of the Most Valuable Psychedelic Stocks

Psychedelics, like psilocybin are going mainstream – and fast. Already, over the last few months, ...

CMPS : 37.20 (-3.10%)
RVVTF : 0.1729 (-4.48%)
MMEDF : 1.0100 (+3.06%)
NUMI.VN : 0.425 (+11.84%)
MCUR.CN : 0.740 (+4.23%)
HAVN.CN : 0.970 (+14.12%)
RVV.CN : 0.225 (-4.26%)
Compass Pathways' Leads the Way as the First Psychedelics Company To IPO on the Nasdaq

, /PRNewswire/ -- Last year may have been all about cannabis, but it's clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since (NYSE:JNJ) ketamine-derived medicine, Spravato,...

AGN : 193.02 (+0.02%)
RVVTF : 0.1729 (-4.48%)
JNJ : 145.04 (-0.14%)
CMPS : 37.20 (-3.10%)
RVV.CN : 0.225 (-4.26%)
ABBV : 84.10 (-0.28%)
MMEDF : 1.0100 (+3.06%)
Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market

, /PRNewswire/ -- Investors are seeing big opportunity in psychedelics based upon the numbers that the nascent cannabis industry has been putting up… after all, last year, worldwide sales of legal cannabis...

PSYC : 0.0092 (-4.17%)
MMEDF : 1.0100 (+3.06%)
SRNE : 7.99 (-1.11%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4050 (-1.70%)
RVV.CN : 0.225 (-4.26%)
RVVTF : 0.1729 (-4.48%)
Stocks in play: Revive Therapeutics Ltd.

Announced that following the U.S. Food & Drug Administration (“U.S. FDA”) approval to proceed with the ...

RVV.CN : 0.225 (-4.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

2nd Resistance Point 0.245
1st Resistance Point 0.235
Last Price 0.225
1st Support Level 0.220
2nd Support Level 0.215

See More

52-Week High 0.460
Fibonacci 61.8% 0.294
Fibonacci 50% 0.242
Last Price 0.225
Fibonacci 38.2% 0.191
52-Week Low 0.025

See More

Business Summary

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar